Kahn SE - Search Results

1

Genetic background determines the extent of islet amyloid formation in human islet amyloid polypeptide transgenic mice.

Hull RL, Watts MR, Kodama K, Shen ZP, Utzschneider KM, Carr DB, Vidal J, Kahn SE. Hull RL, et al. Among authors: kahn se. Am J Physiol Endocrinol Metab. 2005 Oct;289(4):E703-9. doi: 10.1152/ajpendo.00471.2004. Epub 2005 May 17. Am J Physiol Endocrinol Metab. 2005. PMID: 15899941 Free article.

2

Exercise training delineates the importance of B-cell dysfunction to the glucose intolerance of human aging.

Kahn SE, Larson VG, Schwartz RS, Beard JC, Cain KC, Fellingham GW, Stratton JR, Cerqueira MD, Abrass IB. Kahn SE, et al. J Clin Endocrinol Metab. 1992 Jun;74(6):1336-42. doi: 10.1210/jcem.74.6.1592879. J Clin Endocrinol Metab. 1992. PMID: 1592879

3

Glucose stimulates and potentiates islet amyloid polypeptide secretion by the B-cell.

Kahn SE, Fujimoto WY, D'Alessio DA, Ensinck JW, Porte D Jr. Kahn SE, et al. Horm Metab Res. 1991 Dec;23(12):577-80. doi: 10.1055/s-2007-1003759. Horm Metab Res. 1991. PMID: 1723393

4

Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells.

Kahn SE, D'Alessio DA, Schwartz MW, Fujimoto WY, Ensinck JW, Taborsky GJ Jr, Porte D Jr. Kahn SE, et al. Diabetes. 1990 May;39(5):634-8. doi: 10.2337/diab.39.5.634. Diabetes. 1990. PMID: 2185112

5

Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction?

Porte D Jr, Kahn SE. Porte D Jr, et al. Among authors: kahn se. Diabetes. 1989 Nov;38(11):1333-6. doi: 10.2337/diab.38.11.1333. Diabetes. 1989. PMID: 2695369 Review.

6

Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse.

D'Alessio DA, Verchere CB, Kahn SE, Hoagland V, Baskin DG, Palmiter RD, Ensinck JW. D'Alessio DA, et al. Among authors: kahn se. Diabetes. 1994 Dec;43(12):1457-61. doi: 10.2337/diab.43.12.1457. Diabetes. 1994. PMID: 7958499

7

Transgenic mice overproducing islet amyloid polypeptide have increased insulin storage and secretion in vitro.

Verchere CB, D'Alessio DA, Palmiter RD, Kahn SE. Verchere CB, et al. Among authors: kahn se. Diabetologia. 1994 Jul;37(7):725-8. doi: 10.1007/BF00417699. Diabetologia. 1994. PMID: 7958546

8

Evidence for selective release of rodent islet amyloid polypeptide through the constitutive secretory pathway.

Kahn SE, Verchere CB, D'Alessio DA, Cook DL, Fujimoto WY. Kahn SE, et al. Diabetologia. 1993 Jun;36(6):570-3. doi: 10.1007/BF02743276. Diabetologia. 1993. PMID: 8335181

9

Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide.

Verchere CB, D'Alessio DA, Palmiter RD, Weir GC, Bonner-Weir S, Baskin DG, Kahn SE. Verchere CB, et al. Among authors: kahn se. Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3492-6. doi: 10.1073/pnas.93.8.3492. Proc Natl Acad Sci U S A. 1996. PMID: 8622964 Free PMC article.

10

Transgenic overproduction of islet amyloid polypeptide (amylin) is not sufficient for islet amyloid formation.

Verchere CB, D'Alessio DA, Wang S, Andrikopoulos S, Kahn SE. Verchere CB, et al. Among authors: kahn se. Horm Metab Res. 1997 Jun;29(6):311-6. doi: 10.1055/s-2007-979042. Horm Metab Res. 1997. PMID: 9230354 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

568 results

Search Page

Filters